These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
109 related items for PubMed ID: 11093603
21. The value of IgA antiphospholipid testing for diagnosis of antiphospholipid (Hughes) syndrome in systemic lupus erythematosus. Bertolaccini ML, Atsumi T, Escudero Contreras A, Khamashta MA, Hughes GR. J Rheumatol; 2001 Dec; 28(12):2637-43. PubMed ID: 11764209 [Abstract] [Full Text] [Related]
22. Laboratory evaluation of anti-phospholipid syndrome: a preliminary prospective study of phosphatidylserine/prothrombin antibodies in an at-risk patient cohort. Heikal NM, Jaskowski TD, Malmberg E, Lakos G, Branch DW, Tebo AE. Clin Exp Immunol; 2015 May; 180(2):218-26. PubMed ID: 25522978 [Abstract] [Full Text] [Related]
23. Evaluation of a new set of automated chemiluminescense assays for anticardiolipin and anti-beta2-glycoprotein I antibodies in the laboratory diagnosis of the antiphospholipid syndrome. Persijn L, Decavele AS, Schouwers S, Devreese K. Thromb Res; 2011 Dec; 128(6):565-9. PubMed ID: 21529896 [Abstract] [Full Text] [Related]
24. Catastrophic anti-phospholipid syndrome in the absence of IgG anti-cardiolipin antibodies. Kennedy M, Jackson J, Khan I, Keeling PW, Gaffney E. Scand J Rheumatol; 1995 Dec; 24(6):389-91. PubMed ID: 8610226 [Abstract] [Full Text] [Related]
26. Antibodies to beta2-glycoprotein I: a potential marker for clinical features of antiphospholipid antibody syndrome in patients with systemic lupus erythematosus. Sanfilippo SS, Khamashta MA, Atsumi T, Amengual O, Bertolaccini ML, D'Cruz D, Amft N, Swana GT, Hughes GR. J Rheumatol; 1998 Nov; 25(11):2131-4. PubMed ID: 9818654 [Abstract] [Full Text] [Related]
27. Adult heart block is associated with disease activity in primary Sjögren's syndrome. Lodde BM, Sankar V, Kok MR, Leakan RA, Tak PP, Pillemer SR. Scand J Rheumatol; 2005 Nov; 34(5):383-6. PubMed ID: 16234186 [Abstract] [Full Text] [Related]
28. The prevalence and clinical associations of anticardiolipin antibodies in a large inception cohort of patients with connective tissue diseases. Merkel PA, Chang Y, Pierangeli SS, Convery K, Harris EN, Polisson RP. Am J Med; 1996 Dec; 101(6):576-83. PubMed ID: 9003103 [Abstract] [Full Text] [Related]
30. Characterization of IgG monoclonal anti-cardiolipin/anti-beta2GP1 antibodies from two patients with antiphospholipid syndrome reveals three species of antibodies. Zhu M, Olee T, Le DT, Roubey RA, Hahn BH, Woods VL, Chen PP. Br J Haematol; 1999 Apr; 105(1):102-9. PubMed ID: 10233371 [Abstract] [Full Text] [Related]
31. Interaction of giant phospholipid vesicles containing cardiolipin and cholesterol with beta2-glycoprotein-I and anti-beta2-glycoprotein-I antibodies. Ambrozic A, Cucnik S, Tomsic N, Urbanija J, Lokar M, Babnik B, Rozman B, Iglic A, Kralj-Iglic V. Autoimmun Rev; 2006 Nov; 6(1):10-5. PubMed ID: 17110310 [Abstract] [Full Text] [Related]
32. Thrombotic risk assessment and analytical performance of the chemiluminescent analyzer IDS-iSYS for the detection of anti-cardiolipin and anti-beta 2 glycoprotein I autoantibodies. Salma N, Julie L, Boutahar B, Sylvie LN, Eleonore B, Fabien LN, Elisabeth P, Sandrine JJ, Francis C, Sophie H, Yves R. Clin Immunol; 2018 Sep; 194():92-99. PubMed ID: 30017909 [Abstract] [Full Text] [Related]
33. Heterogeneity of antibodies to beta2-glycoprotein 1 from patients with systemic lupus erythematosus. Cabral AR, Cabiedes J, Alarcón-Segovia D. Lupus; 2004 Sep; 13(3):182-7. PubMed ID: 15119547 [Abstract] [Full Text] [Related]
34. Clinical importance of antibodies against platelet activating factor in antiphospholipid syndrome manifestations. Tektonidou MG, Petrovas CA, Ioannidis JP, Vlachoyiannopoulos PG, Moutsopoulos HM. Eur J Clin Invest; 2000 Jul; 30(7):646-52. PubMed ID: 10886305 [Abstract] [Full Text] [Related]
35. Anti-cardiolipin antibodies in patients with chronic viral hepatitis are independent of beta2-glycoprotein I cofactor or features of antiphospholipid syndrome. Zachou K, Liaskos C, Christodoulou DK, Kardasi M, Papadamou G, Gatselis N, Georgiadou SP, Tsianos EV, Dalekos GN. Eur J Clin Invest; 2003 Feb; 33(2):161-8. PubMed ID: 12588291 [Abstract] [Full Text] [Related]
36. Pulmonary hypertension and antiphospholipid antibody in a patient with Sjögren's syndrome. Biyajima S, Osada T, Daidoji H, Hisaoka T, Sakakibara Y, Tajima J, Nakazawa M, Kuroda H, Kobayashi S. Intern Med; 1994 Dec; 33(12):768-72. PubMed ID: 7718958 [Abstract] [Full Text] [Related]
37. Polyarthritis in primary Sjögren's syndrome represents a distinct subset with less pronounced B cell proliferation a Dutch cohort with long-term follow-up. ter Borg EJ, Kelder JC. Clin Rheumatol; 2016 Mar; 35(3):649-55. PubMed ID: 26791875 [Abstract] [Full Text] [Related]
38. [Pulmonary thromboembolism associated with antiphospholipid syndrome in scleroderma]. Tazawa R, Saijo Y, Abe T, Satoh K, Watanabe A, Yamaki S, Nukiwa T. Nihon Kyobu Shikkan Gakkai Zasshi; 1997 Dec; 35(12):1413-7. PubMed ID: 9567091 [Abstract] [Full Text] [Related]
39. Anti beta 2-glycoprotein I antibodies in a patient with catastrophic antiphospholipid syndrome. Pengo V, Biasiolo A, Grazia Fior M, Ruffatti A. Clin Rheumatol; 1995 Nov; 14(6):646-9. PubMed ID: 8608682 [Abstract] [Full Text] [Related]
40. Anti-ribosomal P protein antibodies detected by immunoblotting in patients with connective tissue diseases: their specificity for SLE and association with IgG anticardiolipin antibodies. Ghirardello A, Doria A, Zampieri S, Gerli R, Rapizzi E, Gambari PF. Ann Rheum Dis; 2000 Dec; 59(12):975-81. PubMed ID: 11087701 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]